drugset / Trial / NCT00166166

Endothelial Hyperpolarization in Humans

NCT00166166

Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF.

Timeline

Start
2002-07
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcholine Small molecule 7.5 ug Other
Subject Acetylcholine Small molecule 15 ug Other
Subject Acetylcholine Small molecule 30 ug Other
Subject Bradykinin Protein / enzyme biologic 100 ng Other
Subject Bradykinin Protein / enzyme biologic 200 ng Other
Subject Bradykinin Protein / enzyme biologic 400 ng Other
Subject Fluconazole Small molecule 0.4 unknown Other
Subject L-NMMA Unknown 0.008 mmol Other
Subject Sodium Nitroprusside Unknown 1.6 mg Other
Subject Sodium Nitroprusside Unknown 3.2 mg Other
Subject Tetraethylammonium Unknown 1 mg Other

Indications